Elite Pharmaceuticals (ELTP) Change in Receivables (2009 - 2026)
Elite Pharmaceuticals (ELTP) recorded Change in Receivables of $12.97 million in fiscal Q2 2027 (quarter ended Sep 30, 2026), up 149.8% from $5.19 million a year earlier.
Elite Pharmaceuticals (ELTP) Change in Receivables (2009 - 2026) Analysis & Trends
On a TTM basis, Elite Pharmaceuticals' Change in Receivables came in at $22.68 million as of Sep 30, 2026, up 11.7% year-over-year; for FY2026 (ended Mar 31, 2026), it came in at $31.56 million, up 218.7% from FY2025.
- Across earlier fiscal years, Change in Receivables came in at $9.9 million in FY2025 (-40.3%), $16.6 million in FY2024, $36,636 in FY2023 and -$438,463 in FY2022.
- The fiscal Q2 2027 figure is the highest quarterly Change in Receivables in data going back to fiscal Q3 2010.
- Peak year-over-year performance for Change in Receivables in the last five years was growth of 592.6% in fiscal Q1 2026, against a decline of 79.6% in fiscal Q2 2023 at the low end.
- Per Business Quant, the preceding three fiscal quarters came in at -$9.44 million (Q1 2027), $11.36 million (Q4 2026) and $7.79 million (Q3 2026).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,276.89 Bn | 1,250.50 Bn | 20.46 Bn | - |
| 2 | Johnson & Johnson | 681.31 Bn | 601.18 Bn | 17.30 Bn | -188.00 Mn |
| 3 | AbbVie | 520.63 Bn | 488.64 Bn | 13.12 Bn | -312.00 Mn |
| 4 | Merck | 357.22 Bn | 320.16 Bn | 13.19 Bn | - |
| 5 | Novartis Ag | 310.90 Bn | 284.14 Bn | - | - |
| 6 | Astrazeneca | 285.12 Bn | 258.77 Bn | 13.26 Bn | - |
| 7 | Amgen | 250.23 Bn | 201.89 Bn | 7.58 Bn | 108.00 Mn |
| 8 | Gilead Sciences | 207.56 Bn | 182.67 Bn | 6.73 Bn | -52.00 Mn |
| 9 | Pfizer | 164.42 Bn | 111.77 Bn | 12.56 Bn | - |
| 10 | Elite Pharmaceuticals | 401.23 Mn | 274.64 Mn | 15.99 Mn | 12.97 Mn |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 12.97 Mn |
| Jun 30, 2026 | -9.44 Mn |
| Mar 31, 2026 | 11.36 Mn |
| Dec 31, 2025 | 7.79 Mn |
| Sep 30, 2025 | 5.19 Mn |
| Jun 30, 2025 | 7.22 Mn |
| Mar 31, 2025 | 10.92 Mn |
| Dec 31, 2024 | -3.03 Mn |
| Sep 30, 2024 | 971,928.00 |
| Jun 30, 2024 | 1.04 Mn |
| Mar 31, 2024 | 3.49 Mn |
| Dec 31, 2023 | 5.68 Mn |
| Sep 30, 2023 | 4.22 Mn |
| Jun 30, 2023 | 3.21 Mn |
| Mar 31, 2023 | -2.45 Mn |
| Dec 31, 2022 | 1.32 Mn |
| Sep 30, 2022 | 264,429.00 |
| Jun 30, 2022 | 907,196.00 |
| Mar 31, 2022 | 396,500.00 |
| Dec 31, 2021 | -2.01 Mn |
Elite Pharmaceuticals Change in Receivables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=change-in-receivables&ticker=ELTP&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "change-in-receivables", "ticker": "ELTP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=change-in-receivables&ticker=ELTP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();